IRIS
BRACONI, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.400
EU - Europa 7.256
AS - Asia 2.986
SA - Sud America 566
AF - Africa 91
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 8
Totale 19.322
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.313
GB - Regno Unito 1.930
RU - Federazione Russa 1.295
CN - Cina 1.101
IT - Italia 1.023
SG - Singapore 1.013
IE - Irlanda 794
DE - Germania 550
BR - Brasile 488
SE - Svezia 486
UA - Ucraina 426
FR - Francia 292
HK - Hong Kong 228
FI - Finlandia 175
KR - Corea 171
IN - India 112
VN - Vietnam 111
TR - Turchia 58
ES - Italia 56
CA - Canada 46
BE - Belgio 39
CI - Costa d'Avorio 39
AR - Argentina 37
BD - Bangladesh 35
CZ - Repubblica Ceca 33
PL - Polonia 29
MX - Messico 28
NL - Olanda 27
IR - Iran 24
JP - Giappone 24
ZA - Sudafrica 23
AT - Austria 20
ID - Indonesia 18
PK - Pakistan 15
PT - Portogallo 14
EE - Estonia 12
AU - Australia 10
IQ - Iraq 10
LT - Lituania 10
AE - Emirati Arabi Uniti 9
CH - Svizzera 9
EC - Ecuador 9
UZ - Uzbekistan 8
AZ - Azerbaigian 7
EU - Europa 7
JO - Giordania 7
SA - Arabia Saudita 7
SK - Slovacchia (Repubblica Slovacca) 7
CO - Colombia 6
PY - Paraguay 6
VE - Venezuela 6
BO - Bolivia 5
EG - Egitto 5
KE - Kenya 5
KG - Kirghizistan 5
MA - Marocco 5
NZ - Nuova Zelanda 5
RO - Romania 5
AL - Albania 4
CL - Cile 4
DO - Repubblica Dominicana 4
HU - Ungheria 4
TN - Tunisia 4
AM - Armenia 3
BG - Bulgaria 3
CR - Costa Rica 3
DK - Danimarca 3
GR - Grecia 3
IL - Israele 3
JM - Giamaica 3
PE - Perù 3
SY - Repubblica araba siriana 3
ET - Etiopia 2
GE - Georgia 2
HR - Croazia 2
LB - Libano 2
LK - Sri Lanka 2
NG - Nigeria 2
PH - Filippine 2
PR - Porto Rico 2
SO - Somalia 2
TH - Thailandia 2
UG - Uganda 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BY - Bielorussia 1
GD - Grenada 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
SN - Senegal 1
Totale 19.322
Salva come PNG Salva come JPEG
Città #
Southend 1.712
Dallas 1.050
Fairfield 878
Dublin 784
Menlo Park 730
Singapore 612
Ashburn 562
Chandler 553
Woodbridge 400
Siena 367
Moscow 361
Jacksonville 347
Wilmington 332
Santa Clara 328
Seattle 302
Houston 301
Cambridge 276
Beijing 264
Ann Arbor 238
Hong Kong 224
Hefei 171
Seoul 168
Princeton 164
Nanjing 116
Los Angeles 111
New York 104
Milan 100
Helsinki 92
Florence 82
Boardman 75
Munich 71
San Mateo 59
The Dalles 58
Council Bluffs 52
Shanghai 51
São Paulo 50
Bengaluru 47
Dearborn 46
Buffalo 45
Fremont 45
San Diego 44
Nanchang 43
London 40
Abidjan 39
Izmir 38
Brussels 37
Columbus 35
Ho Chi Minh City 33
Lancaster 33
Shenyang 32
Málaga 28
Rome 28
Stockholm 24
Tianjin 23
Hebei 22
Warsaw 22
Frankfurt am Main 21
Redwood City 21
Brno 20
Changsha 20
Norwalk 19
Jiaxing 18
Tokyo 18
Chicago 17
Denver 17
Orem 17
Redondo Beach 17
Dong Ket 16
Johannesburg 16
Kunming 16
Vienna 16
Zhengzhou 16
Atlanta 15
Belo Horizonte 15
Poplar 15
Renton 15
Turku 15
Brooklyn 14
Hanoi 14
Phoenix 14
Düsseldorf 13
Hangzhou 13
Rio de Janeiro 13
San Francisco 13
Toronto 13
Chennai 12
Manchester 12
Monteroni D'arbia 12
Washington 12
Brasília 11
Curtarolo 11
Guangzhou 11
Jakarta 11
Montreal 11
Nuremberg 11
University Park 11
Delhi 10
Guarulhos 10
Mexico City 10
Nürnberg 9
Totale 13.480
Salva come PNG Salva come JPEG
Nome #
Chondroptosis in alkaptonuric cartilage 453
A new integrated and interactive tool applicable to inborn errors of metabolism: Application to alkaptonuria 450
Homogentisic acid induces morphological and mechanical aberration of ochronotic cartilage in alkaptonuria 376
Amyloidosis, Inflammation, and Oxidative Stress in the Heart of an Alkaptonuric Patient 374
4-Hydroxyphenylpyruvate Dioxygenase and Its Inhibition in Plants and Animals: Small Molecules as Herbicides and Agents for the Treatment of Human Inherited Diseases 357
Histological and Ultrastructural Characterization of Alkaptonuric Tissues 354
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. 343
Smoothened-antagonists reverse homogentisic acid-induced alterations of Hedgehog signaling and primary cilium length in alkaptonuria 341
Beer promotes differentiation and mineralization of human osteoblastic cells: Role of silicon 332
Biochemical and proteomic characterization of alkaptonuric chondrocytes 330
Establishment of Four New Human Primary Cell Cultures from Chemo-Naïve Italian Osteosarcoma Patients 322
Inflammatory and oxidative stress biomarkers in alkaptonuria: data from the DevelopAKUre project 313
Alkaptonuria is a novel human secondary amyloidogenic disease 311
Angiogenesis in alkaptonuria 299
Different factors affecting human ANP amyloid aggregation and their implications in congestive heart failure 281
Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: implications in alkaptonuria. 277
Diagnosis of secondary amyloidosis in alkaptonuria 276
Cytoskeleton Aberrations in Alkaptonuric Chondrocytes 275
Yield Determination of Bioethanol Production of Saccharomyces Cerevisiae Metabolic Process by Mathematical Modelling and In-Vivo 13C-NMR 273
Comparative proteomics in alkaptonuria provides insights into inflammation and oxidative stress 272
Inhibition of para-Hydroxyphenylpyruvate Dioxygenase by Analogues of the Herbicide Nitisinone As a Strategy to Decrease Homogentisic Acid Levels, the Causative Agent of Alkaptonuria 270
An Introduction to Personalized Nutrition 263
Proteomic and redox-proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytes 260
Homogentisic acid induces aggregation and fibrillation of amyloidogenic proteins 258
Wild-type wine Saccharomyces cerevisiae as a tool to evaluate the effects on eukaryotic life of locally used herbicides 254
Interactive alkaptonuria database: investigating clinical data to improve patient care in a rare disease 253
Secondary amyloidosis in an alkaptonuric aortic valve 252
Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis 250
Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis 247
Amyloidosis in alkaptonuria 244
Machine learning application for development of a data-driven predictive model able to investigate quality of life scores in a rare disease 242
Homogentisic acid induces autophagy alterations leading to chondroptosis in human chondrocytes: Implications in Alkaptonuria 241
Comparative analysis of the effects of locally used herbicides and their active ingredients on a wild-type wine Saccharomyces cerevisiae strain 240
Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria 240
Oxidative stress and mechanisms of ochronosis in alkaptonuria 239
Saccharomyces cerevisiae as a Tool to Evaluate the Effects of Herbicides on Eukaryotic Life 232
Machine learning application for patient stratification and phenotype/genotype investigation in a rare disease 232
Helicobacter pylori: immunoproteomics related to different pathologies 230
Antibacterial activity of grape extracts towards cagA positive and cagA negative Helicobacter pylori clinical isolates 230
Prevalence of isolated atrial amyloidosis in young patients affected by congestive heart failure 224
Mapping phosphoproteins in Neisseria meningitidis serogroup A 223
Effects of selenium on oxidative damage and antioxidant enzymes of eukaryotic cells: wine Saccharomyces cerevisiae 220
Proteomics and redox-proteomics of the effects of herbicides on a wild-type wine Saccharomyces cerevisiae strain 218
Suitability of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment 217
Oxidative damage mediated by herbicides on yeast cells 215
Redox proteomics gives insights into the role of oxidative stress in alkaptonuria 214
In vivo NMR study of yeast fermentative metabolism in the presence of ferric irons 209
Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model 209
Foodomics for human health: current status and perspectives 208
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial 208
Metabolic response to exogenous ethanol in yeast: an in vivo NMR and mathematical modelling approach 207
Helicobacter pylori immunoproteomes in case reports of rosacea and chronic urticaria 190
Alkaptonuria 188
Saccharomyces cerevisiae as a model in ecotoxicological studies: a post-genomics perspective 188
Cell and tissue models of alkaptonuria 186
Expanding the proteome database of Meningococcus A 185
Membrane Skeletal Protein S-Glutathionylation in Human Red Blood Cells as Index of Oxidative Stress 185
Post-genomics of bone metabolic dysfunctions and neoplasias 184
Oxidative damage induced by herbicides is mediated by thiol oxidation and hydroperoxides production 183
Supportive use of cyclodextrins as decontamination agents for herbicides 183
Personalized nutrition and omics technologies 182
Surfome analysis of a wild-type wine Saccharomyces cerevisiae strain 180
Postgenomics of Neisseria meningitidis: An update 177
Omics Perspectives in Food Science 173
Linking protein oxidation to environmental pollutants: redox proteomic approaches 165
Omics-based technologies for food authentication and traceability 165
Post-genomics and skin inflammation 164
Bacterial post-genomics approaches for vaccines development 163
The therapy for Helicobacter pylori eradication 155
Diagnosis of Helicobacter pylori infection 149
Rubus ulmifolius Leaf Extract Inhibits Proliferation of Murine Myeloma Cells 148
Sub-lethal ethanol exposure enhances viability and ethanol production in Saccharomyces cerevisiae 143
Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies 136
The analysis of Neisseria meningitidis proteomes: reference maps and their applications 136
Postgenomics of Neisseria meningitidis for vaccines development 135
Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuria 131
Leveraging proteomics in orphan disease research: pitfalls and potential 128
Alkaptonuria: From Molecular Insights to a Dedicated Digital Platform 127
Identification of Helicobacter pylori proteins involved in metronidazole resistance by comparative proteomic analysis 127
Post-genomics of Neisseria meningitidis: an update 120
Proteomics in plant research 120
Models of rare diseases 115
Omics and rare diseases: challenges, applications, and future perspectives 114
Novel identification of expressed genes and functional classification of hypothetical proteins from Neisseria meningitidis serogroup A 114
Helicobacter pylori VacA and CagA virulence factors 114
Helicobacter pylori infection and extra-digestive diseases 111
Subclinical ochronosis features in alkaptonuria: a cross-sectional study 108
Survey on the recent advances in 4-Hydroxyphenylpyruvate Dioxygenase (HPPD) inhibition by diketone and triketone derivatives and congeneric compounds: structural analysis of HPPD/inhibitor complexes and structure-activity relationship considerations 103
Kinetics of different processes in human ANP amyloid formation 89
A Comprehensive In Vitro and In Silico Approach for Targeting 4-Hydroxyphenyl Pyruvate Dioxygenase: Towards New Therapeutics for Alkaptonuria 46
Totale 19.568
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.068
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.068
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.370 0 0 0 0 0 219 98 262 185 331 156 119
2021/20221.586 139 173 118 121 77 62 83 60 86 193 161 313
2022/20231.822 117 188 236 249 167 340 61 155 167 43 54 45
2023/20241.357 47 30 126 65 66 361 427 38 5 14 48 130
2024/20252.657 64 136 328 136 295 132 128 180 258 115 261 624
2025/20264.491 453 884 886 862 1.364 42 0 0 0 0 0 0
Totale 19.568